WormBase Tree Display for RNAi: WBRNAi00071371

WBRNAi00071371 Homol: Homol_homol: Y79H2A:RNAi
  Sequence_info: PCR_product: sjj_Y79H2A.3
  Experiment: Laboratory: RT
    Date: 16 Jul 2007 00:00:00
    Genotype: bIs1(vit-2::GFP); rrf-3(pk1426)
    Temperature: 20
    Delivered_by: Bacterial_feeding
  Inhibits: Predicted_gene: Y79H2A.3a Inferred_automatically: RNAi_primary
      Y79H2A.3e Inferred_automatically: RNAi_primary
      Y79H2A.3d Inferred_automatically: RNAi_primary
      Y79H2A.3c Inferred_automatically: RNAi_primary
      Y79H2A.3b Inferred_automatically: RNAi_primary
      Y79H2A.3f Inferred_automatically: RNAi_primary
    Gene: WBGene00013580 Inferred_automatically: RNAi_primary
    Transcript: Y79H2A.3e.1 Inferred_automatically: RNAi_primary
      Y79H2A.3c.1 Inferred_automatically: RNAi_primary
      Y79H2A.3f.1 Inferred_automatically: RNAi_primary
      Y79H2A.3d.1 Inferred_automatically: RNAi_primary
      Y79H2A.3b.1 Inferred_automatically: RNAi_primary
      Y79H2A.3a.1 Inferred_automatically: RNAi_primary
  Species: Caenorhabditis elegans
  Reference: WBPaper00030951
  Phenotype: WBPhenotype:0000961 Remark: RNAi treatment resulted in an abnormal accumulation of YP170-GFP in the body cavity.
    WBPhenotype:0001425 Remark: RNAi treatment resulted in strong suppression of yolk uptake by oocytes as judged by the abnormal accumulation of YP170-GFP in the body cavity.
  Remark: Primary screen. L1 larval stage was applied to induced RNAi cultures.
  Method: RNAi